Hormonal an inflammatory biomarkers in a group of overweight and obese women;Parámetros hormonales e inflamatorios en un grupo de mujeres con sobrepeso/obesidad

Nutricion Hospitalaria

Volumn 26, Issue 4, 2011, Pages 884-889

  Loria Kohen, V ^a   Gomez Candela C ^a   Fernandez Fernandez C ^a   Zurita Rosa, L ^a   Palma Milla, S ^a   Urbieta, M ^a   Bermejo Lopez L M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Adipokines; Ghrelin; Inflammation; Obesity; Overweight

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HORMONE;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; PHYSIOLOGY;

ADULT; AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HORMONES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; OVERWEIGHT;

EID: 79960687226     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2011.26.4.5158     Document Type: Article

References (34)

1. Pérez Mayorga M. El adipocito como órgano endocrino. Implicaciones fisiopatológicas y terapéuticas. Rev Fac Med 2007; 15 (2): 225-242.
2. Trayhurn P, Bing C, Wood IS. Adipose tissue and adipokines energy regulation from the human perspective. J Nutr 2006; 136 (7 Suppl.): 1935S-1939S.
3. Wellen K, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112 (12): 1785-1708.
4. Recasens M, Ricart W, Fenández-Real JM. Obesidad e inflamación. Rev Med Univ Navarra 2004; 48 (2): 49-54.
5. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. BJN 2004; 92 (3): 347-55.
6. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005; 184 (4): 285-93.
7. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity in associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112 (12): 1796-808.
8. Cachofeiro V, Miana M, Martín-Fernández B, Heras N de las, Lahera V. Obesidad, inflamación y disfunción endotelial. Rev Esp Obes 2006; 4 (4): 195-204.
9. Forster HP, Emanuel E, Grady C. The 2000 revision of the Declaration of Helsinki: a step forward or more confusion? Lancet 2001; 358 (9291): 1449-53.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC.Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28 (7): 412-9.
11. Sociedad Española para el Estudio de la Obesidad. Consenso SEEDO'2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Med Clin (Barc) 2000; 115: 587-97.
12. Ascaso JF, Merchante A, Lorente RI, Real JT, Martinez-Valls J, Carmena R. A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients. Metabolism 1998; 47 (5): 508-13.
13. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996; 19 (10): 1138-41.
14. Barceló Acosta M, Borroto Díaz G, Rodríguez Alonso H. Insulinorresistencia: correlación con la distribución de la grasa en el obeso. Rev Cubana Invest Biomed 2002: 21 (4): 228-34.
15. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med Clin (Barc) 2001; 117 (14): 530-3.
16. Seoane LM, Tovar SA, Caminos JE, Nogueiras R, Diéguez C. Ghrelina: un péptido regulador de la ingesta. Rev Esp Obes 2004; 2 (1): 31-41.
17. Ozkan Y, Aydin S, Donder E, Koca SS, Aydin S, Ozkan B, et al. Effect of orlistat on the total ghrelin and leptin levels in obese patients. J Physiol Biochem 2009; 65 (3): 215-23.
18. Ramírez A MM, Medina MA, Querales CM, Millán BE, Sánchez RCO. Evaluación del efecto de la ingesta de una sobrecarga de glucosa sobre los niveles séricos de la proteína C reactiva y de la 1-antitripsina en mujeres obesas. Nutr Hosp 2008; 23 (4): 340-347.
19. Ramírez Alvarado MM, Sánchez Roitz C, Pérez Díaz A, Millán Brito E. Effect of a high saturated fatty acids load on serum concentrations of C-reactive protein, alpha1-antitrypsin, fibrinogen and alpha1-acid glycoprotein in obese women. Nutr Hosp 2010; 25 (1): 72-9.
20. Kao TW, Lu IS, Liao KC, Lai HY, Loh CH, Kuo HK. Associations between body mass index and serum levels of C-reactive protein. S Afr Med J 2009; 99 (5): 326-30.
21. Wu DM, Chu NF, Shen MH, Chang JB. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol 2003; 56 (1): 94-100.
22. Zulet MA, Puchau B, Navarro C, Martí A, Martínez JA. Inflammatory biomarkers: the link between obesity and associated pathologies. Nutr Hosp 2007; 22 (5): 511-27.
23. Rodríguez Rodríguez E, Navia B, López Sobaler AM, Ortega RM. Vitamin D in overweight/obese women and its relationship with dietetic and anthropometric variables. Obesity 2009; 17 (4): 778-82.
24. Pardina E, Ferrer R, Baena-Fustegueras JA, Lecube A, Fort JM, Vargas V et al. The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese. Obes Surg 2010; 20 (5): 623-32.
25. García Lorda P, Bulló M, Vilà R, Grasa MM del, Alemany M, Salas-Salvadó J. Leptin concentrations do not correlate with fat mass nor with metabolic risk factors in morbidly obese females. Diabetes Nutr Metab 2001; 14 (6): 329-36.
26. Druker R. Regulación del apetito y control hormonal del peso corporal. Fisiología Médica. México D. F.: El Manual Moderno; 2005.
27. Ramel A, Arnarson A, Parra D, Kiely M, Bandarra NM, Martinéz JA et al. Gender difference in the prediction of weight loss by leptin among overweight adults. Ann Nutr Metab 2010; 56 (3): 190-7.
28. Jürimäe J, Jürimäe T, Ring-Dimitriou S, LeMura LM, Arciero PJ, von Duvillard SP. Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women. Metabolism 2009; 58 (5): 638-43.
29. Gnaci Ska M, Małgorzewicz S, Guzek M, Lysiak-Szydłowska W, Sworczak K. Adipose tissue activity in relation to overweight or obesity. Endokrynol Pol 2010; 61 (2): 160-8.
30. Thorand B, Baumert J, Chambless L, Meisinger C, Kolb H, Döring A et al. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol 2006; 26 (2): 398-405.
31. Chen CC, Li TC, Li CI, Liu CS, Wang HJ, Lin CC. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 2005; 54 (4): 471-5.
32. Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K. Interleukin-10 associates with adiponectin predominantly in subjects with metabolic syndrome. Circ J 2007; 71 (8): 1234-8.
33. Hernández Romero A, Matta Campos J, Mora Nieto A, del Rivero L, Andrés Dionicio A, Aguilar Ramírez P et al. Alivio de síntomas clínicos en pacientes obesos con asma moderada persistente secundario a la disminución de obesidad. Revista Alergia México 2008; 55 (3): 103-11.
34. Jung SH, Park HS, Kim KS, Choi WH, Ahn CW, Kim BT, et al. Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss. J Nutr Biochem 2008; 19 (6): 371-5.